| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8440885 | European Journal of Cancer | 2016 | 7 Pages |
Abstract
Beyond the benefit of MIS on immediate surgical outcome, our results show that fear for a poor long-term outcome should not be the reason to refrain from MIS in patients with high-risk endometrial cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Martin Koskas, Marta Jozwiak, Marie Fournier, Ignace Vergote, Hans Trum, Christianne Lok, Frédéric Amant,